Breaking News Instant updates and real-time market news.

UPS

UPS

$108.29

0.39 (0.36%)

, ITW

Illinois Tool Works

$121.07

1.3 (1.09%)

10:37
10/25/18
10/25
10:37
10/25/18
10:37

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. UPS (UPS) downgraded to Neutral from Buy at BofA/Merrill with analyst Ken Hoexter saying Q3 margins deteriorated more than expected with international falling 140bps year-over-year to 16.6%, the lowest level since 2015, and domestic falling 100bps year-over-year to 9.5%, the worst level since 2009. 2. Illinois Tool Works (ITW) downgraded to Neutral from Buy at Seaport Global with analyst Walk Liptak saying Illinois Tool Works is being negatively impacted by pockets of slowing international end markets and slower international auto production. 3. STMicroelectronics (STM) downgraded to Underperform from Outperform at Baird with analyst Tristan Gerra saying the company's lead times remain significantly elevated versus analog/MCU peers, indicating further downside, and expects a "significant" worsening in Q1 2019 quarter-over-quarter revenue comps. 4. Ambev (ABEV) downgraded to Underperform from Neutral at BofA/Merrill and to Underweight from Neutral at JPMorgan. 5. LabCorp (LH) downgraded to Hold from Buy at Canaccord with analyst Mark Massaro citing accelerating reimbursement pressure from PAMA, expected share and profit losses, some contractual changes in managed care, and a disappointing outcome in the ACLA vs. HHS lawsuit. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

UPS

UPS

$108.29

0.39 (0.36%)

ITW

Illinois Tool Works

$121.07

1.3 (1.09%)

STM

STMicroelectronics

$13.72

0.03 (0.22%)

ABEV

Ambev

$3.87

-0.33 (-7.86%)

LH

LabCorp

$157.37

2.03 (1.31%)

  • 13

    Dec

UPS UPS
$108.29

0.39 (0.36%)

10/25/18
10/25/18
DOWNGRADE
Target $116

Neutral
UPS downgraded to Neutral on margin pressures at BofA/Merrill
As previously reported, BofA/Merrill downgraded UPS to Neutral from Buy and lowered its price target to $116 from $145. Analyst Ken Hoexter said Q3 margins deteriorated more than expected with international falling 140bps year-over-year to 16.6%, the lowest level since 2015, and domestic falling 100bps year-over-year to 9.5%, the worst level since 2009. Hoexter expects margins to remain under pressure and notes the company tend to be a economic indicator of the economy.
10/25/18
BOFA
10/25/18
DOWNGRADE
BOFA
Neutral
UPS downgraded to Neutral from Buy at BofA/Merrill
10/01/18
BMOC
10/01/18
UPGRADE
Target $128
BMOC
Outperform
UPS upgraded to Outperform at BMO Capital on 'attractive' risk-reward
As reported earlier, BMO Capital analyst Fadi Chamoun upgraded his rating on UPS to Outperform from Market Perform and kept his price target at $128. The analyst says his meetings with institutional investors give him a more constructive outlook as the company proceeds with efforts to "add capacity across its network, implement automation", and (perform) other cost efficiency initiatives with medium-term benefits. Chamoun adds that in spite of the up-front costs of these measures likely producing lumpy near-term quarterly results, he sees risk-reward as increasingly more attractive for medium-term investors.
10/01/18
10/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Outperform from Market Perform at BMO Capital with analyst Fadi Chamoun saying his meetings with institutional investors give him a more constructive outlook as the company proceeds with efforts to "add capacity across its network, implement automation," and (perform) other cost efficiency initiatives with medium-term benefits. 2. LogMeln (LOGM) upgraded to Outperform from Perform at Oppenheimer analyst Shaul Eyal saying in light of a soft 1H18 performance, the analyst views the company's recent retention concerns as gradually stabilizing per his industry checks. 3. Noble Corp. (NE) upgraded to Neutral from Underweight at Piper Jaffray with analyst Ian Macpherson saying he views the stock's risk/reward as balanced at current share levels. 4. Biogen (BIIB) assumed with an Overweight from Neutral at Cantor Fitzgerald. 5. Teva (TEVA) upgraded to Conviction Buy from Buy at Goldman Sachs and to Market Perform from Underperform at Leerink. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ITW Illinois Tool Works
$121.07

1.3 (1.09%)

10/18/18
WELS
10/18/18
NO CHANGE
Target $150
WELS
Outperform
Illinois Tool Works price target lowered to $150 from $160 at Wells Fargo
Wells Fargo analyst Andrew Casey lowered his price target for Illinois Tool Works to $150 from $160 saying he believes the stock could also see near-term volatility/downside risk as he expects a slight Q3 miss and recalibration down for out-year earnings. Nonetheless, Casey thinks Illinois Tool Works is close to a sentiment shift that could drive better relative performance. The analyst reiterates an Outperform rating on the shares.
10/25/18
GHSC
10/25/18
DOWNGRADE
GHSC
Neutral
Illinois Tool Works downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Walk Liptak downgraded Illinois Tool Works to Neutral from Buy and cut its price target to $132 from $170 following the weak Q3 report. Liptak said Illinois Tool Works is being negatively impacted by pockets of slowing international end markets and slower international auto production. The analyst is moving to the sidelines until he has confidence that that the company can use 80/20 growth strategies to offset cumulative macro headwinds like FX, tough comparisons, slowing international growth and material inflation.
10/12/18
GDHS
10/12/18
INITIATION
Target $139
GDHS
Hold
Illinois Tool Works initiated with a Hold at Gordon Haskett
Gordon Haskett analyst John Inch started Illinois Tool Works with a Hold rating and $139 price target.
10/25/18
WELS
10/25/18
NO CHANGE
Target $145
WELS
Outperform
Illinois Tool Works price target lowered to $145 from $150 at Wells Fargo
Wells Fargo analyst Andrew Casey lowered his price target for Illinois Tool Works to $145 from $150, saying that while he expected a Q3 miss, revenue was even weaker than he anticipated, and this appeared to be largely end market driven. Casey reiterated an Outperform rating on the shares.
STM STMicroelectronics
$13.72

0.03 (0.22%)

09/26/18
DBAB
09/26/18
UPGRADE
DBAB
Buy
STMicroelectronics upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Johannes Schaller upgraded STMicroelectronics to Buy with an unchanged price target of EUR 20. The stock has "suffered too much," setting up for an attractive risk/reward profile at current levels, Schaller tells investors in a research note.
10/25/18
BARD
10/25/18
DOWNGRADE
Target $10
BARD
Underperform
STMicroelectronics downgraded to Underperform from Outperform at Baird
Baird analyst Tristan Gerra double downgraded STMicroelectronics to Underperform from Outperform and slashed its price target to $10 from $28. Gerra said the company's lead times remain significantly elevated versus analog/MCU peers, indicating further downside, and expects a "significant" worsening in Q1 2019 quarter-over-quarter revenue comps. The analyst expects STM to continue to gain content share at Apple (AAPL) but said the gross margin profile will deteriorate in outer years.
09/26/18
09/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIAB) upgraded to Buy from Neutral at B. Riley FBR. 2. GoPro (GPRO) upgraded to Outperform from Perform at Oppenheimer with analyst Andrew Uerkwitz saying he believes the company has done everything it can to position itself for success. 3. STMicroelectronics (STM) upgraded to Buy from Hold at Deutsche Bank with analyst Johannes Schaller saying the stock has "suffered too much," setting up for an attractive risk/reward profile at current levels. 4. IBM (IBM) upgraded to Buy from Neutral at UBS with analyst John Roy saying the market is pricing in a 2% revenue decline, which IBM can beat. 5. Cheniere Energy (LNG) upgraded to Overweight from Equal Weight at Morgan Stanley and to Outperform from Market Perform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/24/18
CHLM
10/24/18
NO CHANGE
Target $20
CHLM
Buy
STMicroelectronics price target lowered to $20 from $28 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss lowered his price target for STMicroelectronics (STM) to $20 from $28 saying that while faring better than peers, itis seeing some weakness primarily in MCU's in China. The analyst notes that investors are likely to throw the "baby out with the bath water" after Texas Instruments (TXN) spoke about softness across the board. But contrary to Texas Instruments, STMicroelectronics is seeing substantial increase in content in Apple (AAPL) phones this year as well as continued increasing content in autos, he contends. Stoss reiterates a Buy rating on the shares.
ABEV Ambev
$3.87

-0.33 (-7.86%)

10/25/18
JPMS
10/25/18
DOWNGRADE
JPMS
Underweight
Ambev downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Lucas Ferreira downgraded Ambev to Underweight. The analyst sees a "challenging" growth outlook for the company following its "weaker" Q3 report.
10/25/18
BOFA
10/25/18
DOWNGRADE
Target $17
BOFA
Underperform
Ambev downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Isabella Simonato downgraded AmBev to Underperform and cut tis price target to $4.30 from $5.40 citing "very weak" Q3 beer volumes in Brazil, mid-teens cost inflation in Brazil, and decelerating earnings growth.
10/02/18
10/02/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GE UPGRADED AT RBC, WOLFE: RBC Capital analyst Deane Dray upgraded General Electric (GE) to Outperform from Sector Perform and raised his price target for the shares to $15 from $13. The analyst believes a floor has been put in the shares following news of Larry Culp being named Chairman and CEO. Additionally, GE was upgraded to Outperform from Peer Perform at Wolfe Research. DEUTSCHE SEES HEIGHTENED RISKS TO FACEBOOK ESTIMATES: After attending the first day of AdWeek, Deutsche Bank analyst Lloyd Walmsley sees heightened risk to the Q3, Q4 and 2019 consensus estimates for Facebook (FB). The analyst said he's starting to hear more cautious feedback and that Facebook seems on the defensive, particularly following last week's data breach disclosure. Walmsley, however, continues to view Facebook as attractively valued and kept a Buy rating on the shares with a $205 price target. JPMORGAN ADDS WEIGHT WATCHERS TO FOCUS LIST: JPMorgan analyst Christina Brathwaite added Weight Watchers (WTW) to her firm's America's Analyst Focus while keeping an Overweight rating on the shares with a $120 price target. The stock's 30% pullback from its peak on June 20 presents a "compelling entry point for investors who missed the stock's appreciation the first time around," Brathwaite said. Despite the post-earnings selloff, the analyst believes the Q2 print was actually indicative that Weight Watchers' growth story remains on track. Further, she believes the changes announced last week, including its new rewards program, as well as the company's Invite a Friend program, will help drive member recruitment and retention going forward. AMBEV DOUBLE DOWNGRADED BY UBS: UBS analyst Alan Alanis double downgraded Ambev (ABEV) to Sell from Buy and lowered his price target for the shares to R$17 from R$23. AmBev trades at a 25% higher valuation than parent company AB InBev (BUD), which is unwarranted, Alanis believes. He believes Ambev shares at current levels are more than pricing in the company's favorable outlook. Further, he expects consensus estimates to come down due to a tougher competitive environment, a "tepid" Brazilian economic recovery and currency headwinds. DEUTSCHE DOWNGRADES METAL STOCKS: Deutsche Bank analyst Jeremy Kliewer downgraded Century Aluminum to Hold from Buy and lowered his price target for the shares to $15 from $20, stating that Century's margins could remain pressured for longer due to alumina supply disruptions. Meanwhile, Deutsche's Chris Terry downgraded Reliance Steel (RS) to Hold from Buy and lowered his price target for the shares to $90 from $100, and downgraded U.S. Steel (X) to Hold from Buy and lowered his price target for the shares to $35 from $47. The analyst said his view on the steel sector is "moderating post peak pricing." Most positive data points and catalysts have now largely played out, Terry believes.
10/02/18
10/02/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman downgraded ConocoPhillips (COP) to Neutral following share outperformance with analyst Neil Mehta citing valuation. 2. U.S. Steel (X) and Reliance Steel (RS) were downgraded to Hold from Buy at Deutsche Bank. 3. Unilever (UN, UL) downgraded to Hold from Buy at Jefferies with analyst Martin Deboo saying the company is facing "choppier waters" and "higher expectations." 4. Ambev (ABEV) double downgraded to Sell from Buy at UBS with analyst Alan Alanis saying AmBev trades at a 25% higher valuation than parent company AB InBev (BUD), which is unwarranted. 5. Schlumberger (SLB) downgraded to Hold from Buy at Tudor Pickering. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LH LabCorp
$157.37

2.03 (1.31%)

10/25/18
ADAM
10/25/18
DOWNGRADE
Target $162
ADAM
Hold
LabCorp downgraded to Hold ahead of "bridge year" at Canaccord
As reported previously, Canaccord analyst Mark Massaro downgraded LabCorp to Hold from Buy. The analyst cited accelerating reimbursement pressure from PAMA, expected share and profit losses, some contractual changes in managed care, and a disappointing outcome in the ACLA vs. HHS lawsuit. He calls 2019 a "bridge year" and moved to the sidelines. Massaro lowered his price target to $162 from $195 on LabCorp shares.
10/25/18
ADAM
10/25/18
DOWNGRADE
ADAM
Hold
LabCorp downgraded to Hold from Buy at Canaccord
10/24/18
PIPR
10/24/18
NO CHANGE
Target $180
PIPR
Overweight
Piper says LabCorp pullback on 'messy' quarter presents longer-term opportunity
Piper Jaffray analyst William Quirk notes that LabCorp shares are down about 6% after the company reported Q3 revenue and ongoing EPS that missed Street estimates, lowered its FY18 revenue and EPS at the midpoint and gave "soft" 2019 guidance suggesting "modest" revenue and earnings growth. Quirk lowered his FY19 EPS view to $11.26 from $11.60 and his price target to $180 from $186, but keeps an Overweight rating on LabCorp shares, as he believes the combination of stable diagnostics and improving Covance will lead to longer-term outperformance.
10/23/18
JPMS
10/23/18
NO CHANGE
JPMS
Overweight
LabCorp recent selloff unwarranted, says JPMorgan

TODAY'S FREE FLY STORIES

IONS

Ionis Pharmaceuticals

$67.35

0.215 (0.32%)

, BIIB

Biogen

$229.80

0.75 (0.33%)

13:01
05/24/19
05/24
13:01
05/24/19
13:01
Hot Stocks
Ionis, Biogen slip after FDA approves Novartis' Zolgensma for SMA treatment »

Shares of Ionis…

IONS

Ionis Pharmaceuticals

$67.35

0.215 (0.32%)

BIIB

Biogen

$229.80

0.75 (0.33%)

NVS

Novartis

$87.21

2.75 (3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

XRT

S&P Retail Index SPDR

$41.58

-0.09 (-0.22%)

13:00
05/24/19
05/24
13:00
05/24/19
13:00
Options
Size four-way put spread in SPDR Retail Trust as shares extend losses »

Size four-way put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGNX

Regenxbio

$43.60

1.11 (2.61%)

, NVS

Novartis

$87.13

2.67 (3.16%)

12:53
05/24/19
05/24
12:53
05/24/19
12:53
Hot Stocks
Regenxbio up 6% after Novartis receives FDA approval for Zolgensma »

Regenxbio (RGNX) will…

RGNX

Regenxbio

$43.60

1.11 (2.61%)

NVS

Novartis

$87.13

2.67 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

NVS

Novartis

$87.04

2.58 (3.05%)

12:47
05/24/19
05/24
12:47
05/24/19
12:47
Hot Stocks
Novartis says wholesale acquisition cost of Zolgensma $2.125M »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TIVO

TiVo

$6.87

0.04 (0.59%)

12:45
05/24/19
05/24
12:45
05/24/19
12:45
Options
TiVo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

12:45
05/24/19
05/24
12:45
05/24/19
12:45
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

VWAGY

Volkswagen

$0.00

(0.00%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Appeals court rules in favor of Volkswagen diesel car owners, Reuters reports »

A German appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$56.30

0.85 (1.53%)

, WCG

WellCare

$267.57

-6.89 (-2.51%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Third Point confirms Centene stake to CNBC, says WellCare deal in best interest »

CNBC tweeted: "Third…

CNC

Centene

$56.30

0.85 (1.53%)

WCG

WellCare

$267.57

-6.89 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

, IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

12:40
05/24/19
05/24
12:40
05/24/19
12:40
Technical Analysis
On The Fly: ETF fund flow highlights »

Flows for the past week…

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

XLK

Technology Select Sector SPDR

$73.62

0.33 (0.45%)

SMH

Market Vectors Semiconductor

$100.37

0.23 (0.23%)

SOXX

iShares PHLX Semiconductor ETF

$180.13

0.06 (0.03%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$119.60

0.14 (0.12%)

EEM

iShares MSCI Emerging Markets ETF

$40.00

0.08 (0.20%)

XLU

Utilities SPDR

$59.99

0.07 (0.12%)

XLV

Health Care Select Sector SPDR

$89.56

0.17 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$126.65

0.46 (0.36%)

, CCOEY

Capcom

$0.00

(0.00%)

12:37
05/24/19
05/24
12:37
05/24/19
12:37
Hot Stocks
Microsoft says Project xCloud can stream more than 3,500 games »

Kareem Choudhry,…

MSFT

Microsoft

$126.65

0.46 (0.36%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

NVS

Novartis

$86.93

2.47 (2.92%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Hot Stocks
Novartis announces FDA approval for Zolgensma »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CNC

Centene

$55.37

-0.08 (-0.14%)

, WCG

WellCare

$273.18

-1.28 (-0.47%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Periodicals
Third Point thinks Centene should consider sale before buying WellCare, WSJ says »

Daniel Loeb's Third…

CNC

Centene

$55.37

-0.08 (-0.14%)

WCG

WellCare

$273.18

-1.28 (-0.47%)

HUM

Humana

$262.97

3.1 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 05

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

  • 13

    Nov

NVS

Novartis

$86.95

2.49 (2.95%)

12:31
05/24/19
05/24
12:31
05/24/19
12:31
Hot Stocks
Breaking Hot Stocks news story on Novartis »

Novartis announces FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

KNX

Knight-Swift

$29.75

-0.65 (-2.14%)

12:30
05/24/19
05/24
12:30
05/24/19
12:30
Options
Volatility play opened in Knight Transportation »

Volatility play opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 13

    Nov

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:27
05/24/19
05/24
12:27
05/24/19
12:27
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Activist Third Point has…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:26
05/24/19
05/24
12:26
05/24/19
12:26
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Third Point thinks…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

FLEX

Flex

$9.39

-0.08 (-0.84%)

12:25
05/24/19
05/24
12:25
05/24/19
12:25
Periodicals
Huawei phone assembler Flex stops production at China factory, NAR says »

Flex, Huawei's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$357.37

6.8 (1.94%)

12:23
05/24/19
05/24
12:23
05/24/19
12:23
Periodicals
SEC probing Boeing disclosures on grounded 737 Max, Bloomberg reports »

The SEC is investigating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SNA

Snap-On

$157.57

0.25 (0.16%)

12:20
05/24/19
05/24
12:20
05/24/19
12:20
Options
Bullish call spread in Snap On will create its biggest open interest »

Bullish call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
05/24/19
05/24
12:17
05/24/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
05/24/19
05/24
12:16
05/24/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$358.20

7.63 (2.18%)

, SMI

SMIC

$5.18

-0.315 (-5.74%)

12:13
05/24/19
05/24
12:13
05/24/19
12:13
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are finishing out…

BA

Boeing

$358.20

7.63 (2.18%)

SMI

SMIC

$5.18

-0.315 (-5.74%)

FL

Foot Locker

$44.14

-8.705 (-16.47%)

HPQ

HP Inc.

$20.06

0.865 (4.51%)

HPE

HP Enterprise

$14.64

0.31 (2.16%)

TSS

TSYS

$110.03

10.42 (10.46%)

GPN

Global Payments

$152.60

4.63 (3.13%)

HIBB

Hibbett Sports

$24.25

4.405 (22.20%)

DVAX

Dynavax

$5.33

-1.03 (-16.20%)

SPLK

Splunk

$117.39

-11.29 (-8.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 09

    Jul

  • 09

    Jul

  • 13

    Nov

ACHC

Acadia

$32.58

0.35 (1.09%)

12:13
05/24/19
05/24
12:13
05/24/19
12:13
Conference/Events
Acadia to hold a strategic update conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BA

Boeing

$357.94

7.365 (2.10%)

12:12
05/24/19
05/24
12:12
05/24/19
12:12
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing off highs, still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

BA

Boeing

$357.77

7.2 (2.05%)

12:12
05/24/19
05/24
12:12
05/24/19
12:12
Periodicals
Breaking Periodicals news story on Boeing »

SEC probing Boeing over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.